ACTIVE

JUBILANT PHARMA

Export PDF

Financial year 2025 · closed on 31/03/2025

Net result

-12,8 k €

+29.7% YoY

Equity

17,6 M €

-0.1% YoY

What does JUBILANT PHARMA do?

JUBILANT PHARMA is a Public limited company incorporated in 2004. Its registered office is in Merelbeke-Melle.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0865.497.049

Incorporation

27/05/2004

Legal form

Public limited company

Registered office

Guldensporenpark 22
9820 Merelbeke-Melle · FlandreSee on map

Contributed capital

16 180 000,00 €

Latest accounts

31/03/2025

Signals

Solid equity

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 19 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007
Income statement
EBITDA	-8,9 k €	+20.4%	-11,2 k €	-35.4%	-8,3 k €	-4.6%	-7,9 k €	+8.5%	-8,7 k €	-36.2%	-6,4 k €	+37.2%	-10,1 k €	-4.9%	-9,6 k €	-46.5%	-6,6 k €	+14.0%	-7,7 k €	+9.7%	-8,5 k €	-14.4%	-7,4 k €	+5.3%	-7,8 k €	-106%	-3,8 k €	+33.9%	-5,7 k €	-0.3%	-5,7 k €	+75.2%	-23,1 k €	-46.0%	-15,8 k €	-338%	-3,6 k €
Operating result	-8,9 k €	+20.4%	-11,2 k €	-35.4%	-8,3 k €	-4.6%	-7,9 k €	+8.5%	-8,7 k €	-36.2%	-6,4 k €	+37.2%	-10,1 k €	-4.9%	-9,6 k €	-46.5%	-6,6 k €	+14.0%	-7,7 k €	+9.7%	-8,5 k €	-14.4%	-7,4 k €	+5.3%	-7,8 k €	-106%	-3,8 k €	+33.9%	-5,7 k €	-0.3%	-5,7 k €	+79.4%	-27,8 k €	-35.4%	-20,5 k €	-147%	-8,3 k €
Net result	-12,8 k €	+29.7%	-18,2 k €	-119%	-8,3 k €	-4.6%	-7,9 k €	+8.5%	-8,7 k €	-36.2%	-6,4 k €	+37.3%	-10,1 k €	+2.8%	-10,4 k €	-46.9%	-7,1 k €	+12.9%	-8,2 k €	+5.8%	-8,7 k €	-14.5%	-7,6 k €	+3.3%	-7,8 k €	-118%	-3,6 k €	+37.2%	-5,7 k €	-2.9%	-5,6 k €	-15.0%	-4,8 k €	+92.9%	-67,9 k €	-4.8%	-64,8 k €
Balance sheet
Equity	17,6 M €	-0.1%	17,7 M €	-0.1%	17,7 M €	-0.0%	17,7 M €	-0.0%	17,7 M €	-0.0%	17,7 M €	-0.0%	17,7 M €	-0.1%	17,7 M €	-0.1%	17,7 M €	-0.0%	17,7 M €	-0.0%	17,7 M €	-0.0%	17,7 M €	-0.0%	17,8 M €	-0.0%	17,8 M €	-0.0%	17,8 M €	-0.0%	17,8 M €	+2.7%	17,3 M €	+11.6%	15,5 M €	-0.4%	15,6 M €
Total assets	17,7 M €	-0.0%	17,7 M €	+0.0%	17,7 M €	0.0%	17,7 M €	0.0%	17,7 M €	0.0%	17,7 M €	0.0%	17,7 M €	-0.0%	17,7 M €	-0.2%	17,8 M €	-0.0%	17,8 M €	-0.0%	17,8 M €	-0.0%	17,8 M €	-0.0%	17,8 M €	-0.0%	17,8 M €	-0.0%	17,8 M €	-0.0%	17,8 M €	+2.7%	17,3 M €	+3.5%	16,7 M €	+7.3%	15,6 M €
Cash	362,1 €	-76.5%	1,5 k €		–		–		–		–		–		–		36,6 k €	+3724%	956,9 €	-33.9%	1,4 k €	-10.6%	1,6 k €	-8.3%	1,8 k €	-2.2%	1,8 k €	+13.3%	1,6 k €	-63.8%	4,4 k €	-37.1%	7 k €	+430%	1,3 k €	-86.4%	9,7 k €
Debts	86,5 k €	+12.7%	76,8 k €	+39.1%	55,2 k €	+17.6%	46,9 k €	+20.3%	39 k €	+28.5%	30,4 k €	+26.5%	24 k €	+73.2%	13,9 k €	-65.4%	40 k €	+19.7%	33,4 k €	+29.7%	25,8 k €	+49.2%	17,3 k €	+75.5%	9,8 k €	+384%	2 k €	-59.3%	5 k €	+150%	2 k €	-60.2%	5 k €	-99.6%	1,2 M €	+199852%	605 €

Estimate

Indicative valuation

As an indication, this company is worth

between 10 M€ and 25 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/03/2025 · 4 active · 41 ended

Active mandates

Michael Van Ohlen

Director · since 31 octobre 2023 · until 31 mars 2028

Active

Rajesh Bhatia

Director · since 15 mars 2023 · until 01 septembre 2028

Active

Sanjeev Rajapi Dr. Jaidev

Director · since 15 mars 2023 · until 01 septembre 2028

Active

Guiliano Perfetti

Director · since 27 août 2021 · until 01 septembre 2027

Active

Ended mandates

Michael Van Ohlen

Director · since 30 octobre 2023

Ended

Rajapi Dr. Jaidev Sanjeev

Director · since 15 mars 2023 · until 01 septembre 2028

Ended

Guiliano Perfetti

Director · since 27 août 2021

Ended

Mitchell Guss

Director · since 30 décembre 2020 · until 31 octobre 2023

Ended

At this address

Other companies at this address

Company	CBE no.
JUBILANT LIFE SCIENCES● Active	0536.745.342
JUBILANT PHARMACEUTICALS● Active	0454.891.594
PSI SUPPLY● Active	0480.185.731

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/04/2024	01/04/2023	01/04/2022	01/04/2021	01/04/2020	01/04/2019
Closing of the financial year	31/03/2025	31/03/2024	31/03/2023	31/03/2022	31/03/2021	31/03/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	06/10/2025	02/10/2024	27/10/2023	27/10/2022	30/09/2021	29/10/2020
General meeting	26/09/2025	30/09/2024	25/09/2023	07/09/2022	01/09/2021	30/09/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

19 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/03/2025	26/09/2025	06/10/2025	Dutch	PDF
Full model	31/03/2024	30/09/2024	02/10/2024	Dutch	PDF
Full model	31/03/2023	25/09/2023	27/10/2023	Dutch	PDF
Full model	31/03/2022	07/09/2022	27/10/2022	Dutch	PDF
Full model	31/03/2021	01/09/2021	30/09/2021	Dutch	PDF
Full model	31/03/2020	30/09/2020	29/10/2020	Dutch	PDF
Full model	31/03/2019	30/09/2019	30/10/2019	Dutch	PDF
Full model	31/03/2018	30/09/2018	25/10/2018	Dutch	PDF
Full model	31/03/2017	01/09/2017	26/10/2017	Dutch	PDF
Full model	31/03/2016	01/09/2016	26/09/2016	Dutch	PDF
Full model	31/03/2015	01/09/2015	29/09/2015	Dutch	PDF
Full model	31/03/2014	01/09/2014	29/09/2014	Dutch	PDF
Full model	31/03/2013	23/08/2013	19/09/2013	Dutch	PDF
Full model	31/03/2012	05/09/2012	04/10/2012	Dutch	PDF
Full model	31/03/2011	07/09/2011	05/10/2011	Dutch	PDF
Full model	31/03/2010	01/09/2010	07/10/2010	Dutch	PDF
Full model	31/03/2009	02/09/2009	22/10/2009	Dutch	PDF
Full model	31/03/2008	03/09/2008	27/11/2008	Dutch	PDF
Full model	31/03/2007	05/09/2007	30/11/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 10 M€ and 25 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/03/2025 · 4 active · 41 ended

Active mandates

Michael Van Ohlen

Director · since 31 octobre 2023 · until 31 mars 2028

Active

Rajesh Bhatia

Director · since 15 mars 2023 · until 01 septembre 2028

Active

Sanjeev Rajapi Dr. Jaidev

Director · since 15 mars 2023 · until 01 septembre 2028

Active

Guiliano Perfetti

Director · since 27 août 2021 · until 01 septembre 2027

Active

Ended mandates

Michael Van Ohlen

Director · since 30 octobre 2023

Ended

Rajapi Dr. Jaidev Sanjeev

Director · since 15 mars 2023 · until 01 septembre 2028

Ended

Guiliano Perfetti

Director · since 27 août 2021

Ended

Mitchell Guss

Director · since 30 décembre 2020 · until 31 octobre 2023

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates14/08/2026
Kennisname ontslag bestuurder
PDF
Registered office11/02/2026
MAATSCHAPPELIJKE ZETEL
PDF
Other19/09/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates01/02/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates20/04/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates24/01/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates18/01/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates27/09/2021
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025-12,8 k €↑
2024
Annual accounts 2024-18,2 k €↓
2023
Annual accounts 2023-8,3 k €↓
2022
Annual accounts 2022-7,9 k €↑
2021
Annual accounts 2021-8,7 k €↓
2020
Annual accounts 2020-6,4 k €↑
2019
Annual accounts 2019-10,1 k €↑
2018
Annual accounts 2018-10,4 k €↓
2017
Annual accounts 2017-7,1 k €↑
2016
Annual accounts 2016-8,2 k €↑
2015
Annual accounts 2015-8,7 k €↓
2014
Annual accounts 2014-7,6 k €↑
2013
Annual accounts 2013-7,8 k €↓
2012
Annual accounts 2012-3,6 k €↑
2011
Annual accounts 2011-5,7 k €↓
2010
Annual accounts 2010-5,6 k €↓
2009
Annual accounts 2009-4,8 k €↑
2008
Annual accounts 2008-67,9 k €↓
2007
Annual accounts 2007-64,8 k €
27/05/2004
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

JUBILANT PHARMA

Overview

What does JUBILANT PHARMA do?

Trend over 19 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline